Evidence map›Paper›PMID 42010845›Full record

ArticleCritical care explorations2026

Functional Pharmacobezoar and Bowel Ischemia Requiring Hemicolectomy Complicating Extended-Release Carbamazepine-Venlafaxine Overdose.

Mirna Gerges, Abigail Greek, Sarah McMullen

Abstract readCase Reports
In one paragraph

Article in Critical care explorations, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mirna GergesDalhousie University Faculty of Medicine, Halifax, NS, Canada.ORCID 0009-0002-9266-9897
Abigail GreekDalhousie University Faculty of Medicine, Halifax, NS, Canada.
Sarah McMullenDalhousie University Faculty of Medicine, Halifax, NS, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOverdoses of extended-release (ER) medications can cause life-threatening toxicity from prolonged gastrointestinal drug retention due to pharmacobezoar formation. This may result in severe complications including delayed serotonin syndrome and intestinal ischemia despite early use of enhanced elimination strategies. CASE SUMMARY: A 45-year-old woman presented with altered mental status following carbamazepine-venlafaxine ER overdose. Initial carbamazepine concentration was 163 μmol/L. She suffered a ventricular tachycardia arrest requiring venoarterial extracorporeal membrane oxygenation and enhanced elimination with continuous renal replacement therapy (CRRT). After CRRT, carbamazepine concentration rebounded from 33 to 80 μmol/L and clinical features of serotonin syndrome developed suggesting ongoing absorption. CT revealed cecal pneumatosis with obstruction. Laparotomy at day 9 revealed transmural ischemic necrosis with 4-6 L of retained charcoal and polyethylene glycol mixture; source control required a right hemicolectomy. Carbamazepine concentration declined postoperatively and serotonergic symptoms resolved.

conclusionsCarbamazepine-venlafaxine ER overdose with retained pill fragments can cause a variety of complications including prolonged toxicity. Rebounding drug concentration following enhanced elimination should trigger an investigation for gastrointestinal sequestration and prompt surgical consultation.

Indexed as

BezoarsCarbamazepineColectomyDrug OverdoseIschemiaVenlafaxine HydrochlorideDelayed-Action PreparationsFemaleHumansMiddle AgedCarbamazepineDelayed-Action PreparationsVenlafaxine Hydrochloridebowel ischemiacarbamazepine toxicitypharmacobezoarpneumatosisserotonin syndromevenlafaxine overdose

Identifiers

PMID42010845
PMCPMC13098777

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.